Fancl Corp
TSE:4921
Fancl Corp
Cash Equivalents
Fancl Corp
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
F
|
Fancl Corp
TSE:4921
|
Cash Equivalents
¥42.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
8%
|
Shiseido Co Ltd
TSE:4911
|
Cash Equivalents
¥90.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Cash Equivalents
¥89.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Cash Equivalents
¥47.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
3%
|
|
Kao Corp
TSE:4452
|
Cash Equivalents
¥245.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Cash Equivalents
¥62.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
See Also
What is Fancl Corp's Cash Equivalents?
Cash Equivalents
42.1B
JPY
Based on the financial report for Mar 31, 2024, Fancl Corp's Cash Equivalents amounts to 42.1B JPY.
What is Fancl Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
8%
Over the last year, the Cash Equivalents growth was 14%. The average annual Cash Equivalents growth rates for Fancl Corp have been 18% over the past three years , 18% over the past five years , and 8% over the past ten years .